<DOC>
	<DOCNO>NCT01969331</DOCNO>
	<brief_summary>The aim study establish efficacy safety Normia速 probiotic , use add-on therapy treatment H. Pylori infection standard triple therapy approach . The primary objective study determination efficacy Normia速 probiotic supportive therapy achieve high percentage eradication H. Pylori . The secondary objective ass : - Safety profile Normia速 probiotic everyday use , e.g . reduction number side-effects well compliance eradication therapy - Safety efficacy Normia速 probiotic different demographic subgroup</brief_summary>
	<brief_title>Efficacy Safety Probiotic Treatment Supportive Therapy Eradication H. Pylori</brief_title>
	<detailed_description>Gastroenterologists general practitioner increasingly possibility prescribe probiotic preparation ( often ) adjuvant therapy certain indication . A significant step forward make current report European Helicobacter Study Group , state `` Certain probiotic prebiotics show promising result adjuvant treatment reduce side effect '' . At stage , probiotic classify Grade D recommendation . That precisely investigator believe clinical study necessary order effect objectively proven clinical setting . The investigator decide conduct clinical trial base clearly define sufficiently frequent indication , preparation know probiotic composition easily available market , real set approach bound show advantage disadvantage .</detailed_description>
	<mesh_term>Helicobacter Infections</mesh_term>
	<mesh_term>Titanium dioxide</mesh_term>
	<criteria>Confirmed H. Pylori infection . Otherwise healthy subject take H. pylori eradication therapy . Age 16 year . Male female subject . Subject provide write informed consent prior undergo study procedure . Pregnancy lactation . Severe disease malignant disease , severe renal/liver impairment , HIV infection etc . Chronic disease diabetes mellitus , hypertension , epilepsy atherosclerosis treatment well regulate exclusion criterion . Subject mentally capable adhere protocol . Drug addiction alcoholism . Any clinical condition , opinion attend physician , would allow safe administration study medication . Subjects participate clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>Gastritis</keyword>
	<keyword>Helicobacter pylorus</keyword>
</DOC>